7 Results for "

TGFβRI-IN-5

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "TGFβRI-IN-5" in MCE Product Catalog:

Cat. No.: HY-147786
CAS No.: 2541690-15-5
Target:  

TGF-β Receptor

Research Areas:  

Cancer

TGFβRI-IN-5 (Compound 4b) is a potent inhibitor of TGFβRI with an IC50 of 0.08 μM. TGFβRI-IN-5 displays amazing anticancer activity 5–7 times that of reference agent against all the tested cell lines. TGFβRI-IN-5 enhances apoptosis and arrested G2/M phase of cell cycle .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-13227
CAS No.: 627536-09-8
Purity:  99.44%
Target:  

TGF-β Receptor

Research Areas:  

Cancer

SD-208 is a selective TGF-βRI (ALK5) inhibitor with IC50 of 48 nM, and > 100-fold selectivity over TGF-βRII.
loading...
    loading...
Cat. No.: HY-144043
CAS No.: 2705900-81-6
Purity:  98.06%
Target:  

TGF-β Receptor

Research Areas:  

Cancer

ALK5-IN-8 is a potent inhibitor of TGFβRI (ALK5). ALK5-IN-8 Inhibits the phosphorylation of ALK5 on its downstream signaling proteins (Smad2 or Smad3) by blocking the binding of TGFβRI to ligands, thereby affecting or blocking TGF-β signaling. ALK5-IN-8 has the potential for the research of various ALK5-mediated related diseases (extracted from patent WO2021190425A1, compound 1) .
loading...
    loading...
Cat. No.: HY-178231
CAS No.: 2766583-86-0
Synonyms: ALK5-IN-85
Target:  

TGF-β Receptor

Research Areas:  

Inflammation/Immunology Cancer

Finbosertib (ALK5-IN-85) (Compound 19) is a TGFβRI (ALK5) inhibitor with an IC50 of <100 nM. Finbosertib can be used for respiratory diseases including idiopathic pulmonary fibrosis, asthma, COPD and lumg cancer, and dermal and ocular fibrotic conditions research .
loading...
    loading...
Cat. No.: HY-144437
CAS No.: 2489611-06-3
Target:  

TGF-β Receptor

Research Areas:  

Cancer

ALK5-IN-9 (Compound 8h) is a potent and orally active inhibitor of TGFβRI (ALK5). ALK5-IN-9 inhibits ALK5 autophosphorylation and NIH3T3 cell activity with IC50 values of 25 nM and 74.6 nM, respectively. ALK5-IN-9 also shows favorable pharmacokinetic profile and ameliorated hERG inhibition. ALK5-IN-9 has the potential for the research of cancer disease .
loading...
    loading...
Cat. No.: HY-13227R
CAS No.: 627536-09-8
Target:  

TGF-β Receptor

Research Areas:  

Cancer

SD-208 (Standard) is the analytical standard of SD-208. This product is intended for research and analytical applications. SD-208 is a selective TGF-βRI (ALK5) inhibitor with IC50 of 48 nM, and > 100-fold selectivity over TGF-βRII.
loading...
    loading...
Cat. No.: HY-13227G
CAS No.: 627536-09-8
SD-208 (GMP) is SD-208 (HY-13227) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. SD-208 is a selective TGF-βRI (ALK5) inhibitor with IC50 of 48 nM, and > 100-fold selectivity over TGF-βRII.
loading...
    loading...